Podcast
In this first episode of the new series, Executive Director of the Chacruna Institute Bia Labate, PhD, and Kelan Thomas, PharmD, MS, associate professor of clinical sciences at the Touro University California College of Pharmacy, discussed the global psychedelic medicine market.
Today's episode marks the first part of our newest series—Psychedelic Pharmacy! Each episode will explore the growing body of research about psychedelic medicine, with interviews from researchers, clinicians, and other experts.
In this first episode, Executive Director of the Chacruna Institute Bia Labate, PhD, and Kelan Thomas, PharmD, MS, associate professor of clinical sciences at the Touro University California College of Pharmacy, discussed the global psychedelic medicine market.
FDA Approves Bimekizumab-Bkzx as Treatment for Hidradenitis Suppurativa